Sarcopenic obesity in cancer

1. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000; 904: 437–48. doi: 10.1111/j.1749-6632.2000.tb06498.x BaumgartnerRN Body composition in healthy aging Ann N Y Acad Sci 2000 904 437 48 10.1111/j.1749-6632.2000.tb06498.x Open DOISearch in Google Scholar

2. Barazzoni R, Bischoff SC, Boirie Y, Busetto L, Cederholm T, Dicker D, et al. Sarcopenic obesity: Time to meet the challenge. Clin Nutr 2018; 37(6 Pt A): 1787–93. doi: 10.1016/j.clnu.2018.04.018 BarazzoniR BischoffSC BoirieY BusettoL CederholmT DickerD Sarcopenic obesity: Time to meet the challenge Clin Nutr 2018 37 6 Pt A 1787 93 10.1016/j.clnu.2018.04.018 Open DOISearch in Google Scholar

3. Gao Q, Mei F, Shang Y, Hu K, Chen F, Zhao L, et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin Nutr 2021; 40: 4633–41. doi: 10.1016/j.clnu.2021.06.009 GaoQ MeiF ShangY HuK ChenF ZhaoL Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis Clin Nutr 2021 40 4633 41 10.1016/j.clnu.2021.06.009 Open DOISearch in Google Scholar

4. Gao Q, Hu K, Gao J, Shang Y, Mei F, Zhao L, et al. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis. Nutrition 2022; 101: 111704. doi: 10.1016/j.nut.2022.111704 GaoQ HuK GaoJ ShangY MeiF ZhaoL Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis Nutrition 2022 101 111704 10.1016/j.nut.2022.111704 Open DOISearch in Google Scholar

5. Gortan Cappellari G, Brasacchio C, Laudisio D, Lubrano C, Pivari F, Barrea L, et al. Sarcopenic obesity: what about in the cancer setting? Nutrition 2022; 98: 111624. doi: 10.1016/j.nut.2022.111624 Gortan CappellariG BrasacchioC LaudisioD LubranoC PivariF BarreaL Sarcopenic obesity: what about in the cancer setting? Nutrition 2022 98 111624 10.1016/j.nut.2022.111624 Open DOISearch in Google Scholar

6. Carneiro IP, Mazurak VC, Prado CM. Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep 2016; 18: 62. doi: 10.1007/s11912-016-0546-5 CarneiroIP MazurakVC PradoCM Clinical implications of sarcopenic obesity in cancer Curr Oncol Rep 2016 18 62 10.1007/s11912-016-0546-5 Open DOISearch in Google Scholar

7. Atkins JL, Wannamathee SG. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality. Br J Nutr 2020; 124: 1102–13. doi: 10.1017/S0007114520002172 AtkinsJL WannamatheeSG Sarcopenic obesity in ageing: cardiovascular outcomes and mortality Br J Nutr 2020 124 1102 13 10.1017/S0007114520002172 Open DOISearch in Google Scholar

8. Silveira EA, da Silva Filho RR, Spexoto MCB, Haghighatdoost F, Sarrafzadegan N, de Oliveira C. The role of sarcopenic obesity in cancer and cardiovascular disease: a synthesis of the evidence on pathophysiological aspects and clinical implications. Int J Mol Sci 2021; 22: 4339. doi: 10.3390/ijms22094339 SilveiraEA da Silva FilhoRR SpexotoMCB HaghighatdoostF SarrafzadeganN de OliveiraC The role of sarcopenic obesity in cancer and cardiovascular disease: a synthesis of the evidence on pathophysiological aspects and clinical implications Int J Mol Sci 2021 22 4339 10.3390/ijms22094339 Open DOISearch in Google Scholar

9. Donini LM, Busetto L, Bischoff SC, Cederholm T, Ballesteros-Pomar MD, Batsis JA, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts 2022; 15: 321–35. doi: 10.1159/000521241 DoniniLM BusettoL BischoffSC CederholmT Ballesteros-PomarMD BatsisJA Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement Obes Facts 2022 15 321 35 10.1159/000521241 Open DOISearch in Google Scholar

10. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018; 14: 513–37. doi: 10.1038/s41574-018-0062-9 BatsisJA VillarealDT Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies Nat Rev Endocrinol 2018 14 513 37 10.1038/s41574-018-0062-9 Open DOISearch in Google Scholar

11. Chargi N, Bril SI, Swartz JE, Wegner I, Willems SM, de Bree R. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma. Oral Oncol 2020; 101: 104519. doi: 10.1016/j.oraloncology.2019.104519 ChargiN BrilSI SwartzJE WegnerI WillemsSM de BreeR Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma Oral Oncol 2020 101 104519 10.1016/j.oraloncology.2019.104519 Open DOISearch in Google Scholar

12. Kiss N, Beraldo J, Everitt S. Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival. Support Care Cancer 2019; 27: 2657–64. doi: 10.1007/s00520-018-4563-9 KissN BeraldoJ EverittS Early skeletal muscle loss in non-small cell lung cancer patients receiving chemoradiation and relationship to survival Support Care Cancer 2019 27 2657 64 10.1007/s00520-018-4563-9 Open DOISearch in Google Scholar

13. Recio-Boiles A, Galeas JN, Goldwasser B, Sanchez K, Man LMW, Gentzler RD, et al. Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT). Support Care Cancer 2018; 26: 2353–59. doi: 10.1007/s00520-018-4051-2 Recio-BoilesA GaleasJN GoldwasserB SanchezK ManLMW GentzlerRD Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT) Support Care Cancer 2018 26 2353 59 10.1007/s00520-018-4051-2 Open DOISearch in Google Scholar

14. Lodewick TM, van Nijnatten TJ, van Dam RM, van Mierlo K, Dello SA, Neumann UP, et al. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford) 2015; 17: 438–46. doi: 10.1111/hpb.12373 LodewickTM van NijnattenTJ van DamRM van MierloK DelloSA NeumannUP Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford) 2015 17 438 46 10.1111/hpb.12373 Open DOISearch in Google Scholar

15. Grotenhuis BA, Shapiro J, van Adrichem S, de Vries M, Koek M, Wijnhoven BP, et al. Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer. World J Surg 2016; 40: 2698–704. doi: 10.1007/s00268-016-3603-1 GrotenhuisBA ShapiroJ van AdrichemS de VriesM KoekM WijnhovenBP Sarcopenia/muscle mass is not a prognostic factor for short- and long-term outcome after esophagectomy for cancer World J Surg 2016 40 2698 704 10.1007/s00268-016-3603-1 Open DOISearch in Google Scholar

16. Kim YM, Kim JH, Baik SJ, Chun J, Youn YH, Park H. Sarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study. Front Oncol 2019; 9: 1249. doi: 10.3389/fonc.2019.01249 KimYM KimJH BaikSJ ChunJ YounYH ParkH Sarcopenia and sarcopenic obesity as novel risk factors for gastric carcinogenesis: a health checkup cohort study Front Oncol 2019 9 1249 10.3389/fonc.2019.01249 Open DOISearch in Google Scholar

17. Lou N, Chi CH, Chen XD, Zhou CJ, Wang SL, Zhuang CL, et al. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study. Eur J Surg Oncol 2017; 43: 188–95. doi: 10.1016/j.ejso.2016.09.006 LouN ChiCH ChenXD ZhouCJ WangSL ZhuangCL Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study Eur J Surg Oncol 2017 43 188 95 10.1016/j.ejso.2016.09.006 Open DOISearch in Google Scholar

18. Nishigori T, Tsunoda S, Okabe H, Tanaka E, Hisamori S, Hosogi H, et al. Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy. Ann Surg Oncol 2016; 23(Suppl 4): 524–31. doi: 10.1245/s10434-016-5385-y NishigoriT TsunodaS OkabeH TanakaE HisamoriS HosogiH Impact of sarcopenic obesity on surgical site infection after laparoscopic total gastrectomy Ann Surg Oncol 2016 23 Suppl 4 524 31 10.1245/s10434-016-5385-y Open DOISearch in Google Scholar

19. Palmela C, Velho S, Agostinho L, Branco F, Santos M, Santos MP, et al. Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer. J Gastric Cancer 2017; 17: 74–87. doi: 10.5230/jgc.2017.17.e8 PalmelaC VelhoS AgostinhoL BrancoF SantosM SantosMP Body composition as a prognostic factor of neoadjuvant chemotherapy toxicity and outcome in patients with locally advanced gastric cancer J Gastric Cancer 2017 17 74 87 10.5230/jgc.2017.17.e8 Open DOISearch in Google Scholar

20. Sugawara K, Yamashita H, Okumura Y, Yagi K, Yoshimura S, Kawasaki K, et al. Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients. Support Care Cancer 2020; 28: 2797–803. doi: 10.1007/s00520-019-05110-7 SugawaraK YamashitaH OkumuraY YagiK YoshimuraS KawasakiK Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients Support Care Cancer 2020 28 2797 803 10.1007/s00520-019-05110-7 Open DOISearch in Google Scholar

21. Zhang WT, Lin J, Chen WS, Huang YS, Wu RS, Chen XD, et al. Sarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study. J Gastrointest Surg 2018; 22: 1861–69. doi: 10.1007/s11605-018-3835-5 ZhangWT LinJ ChenWS HuangYS WuRS ChenXD Sarcopenic obesity is associated with severe postoperative complications in gastric cancer patients undergoing gastrectomy: a prospective study J Gastrointest Surg 2018 22 1861 69 10.1007/s11605-018-3835-5 Open DOISearch in Google Scholar

22. Giani A, Famularo S, Riva L, Tamini N, Ippolito D, Nespoli L, et al. Association between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection. Nutrition. 2020; 75–76: 110779. doi: 10.1016/j.nut.2020.110779 GianiA FamularoS RivaL TaminiN IppolitoD NespoliL Association between specific presurgical anthropometric indexes and morbidity in patients undergoing rectal cancer resection Nutrition 2020 75–76 110779 10.1016/j.nut.2020.110779 Open DOISearch in Google Scholar

23. Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO, et al. Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treat 2020; 52: 563–72. doi: 10.4143/crt.2019.249 HanJS RyuH ParkIJ KimKW ShinY KimSO Association of body composition with long-term survival in non-metastatic rectal cancer patients Cancer Res Treat 2020 52 563 72 10.4143/crt.2019.249 Open DOISearch in Google Scholar

24. Malietzis G, Currie AC, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R, et al. Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 2016; 103: 572–80. doi: 10.1002/bjs.10075 MalietzisG CurrieAC AthanasiouT JohnsN AnyameneN Glynne-JonesR Influence of body composition profile on outcomes following colorectal cancer surgery Br J Surg 2016 103 572 80 10.1002/bjs.10075 Open DOISearch in Google Scholar

25. Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K. Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resecTable pancreatic ductal adenocarcinoma. PLoS One 2020; 15: e0244896. doi: 10.1371/journal.pone.0244896. Erratum for: PLoS One 2019 6; 14: e0215915. doi: 10.1371/journal.pone.0215915 GruberES JomrichG TamandlD GnantM SchindlM SahoraK Correction: Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resecTable pancreatic ductal adenocarcinoma PLoS One 2020 15 e0244896 10.1371/journal.pone.0244896 Erratum for: PLoS One 2019 6; 14: e0215915. 10.1371/journal.pone.0215915 Open DOISearch in Google Scholar

26. Kobayashi A, Kaido T, Hamaguchi Y, Okumura S, Shirai H, Yao S, et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg 2019; 269: 924–31. doi: 10.1097/SLA.0000000000002555 KobayashiA KaidoT HamaguchiY OkumuraS ShiraiH YaoS Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma Ann Surg 2019 269 924 31 10.1097/SLA.0000000000002555 Open DOISearch in Google Scholar

27. Kimura Y, Yamada M, Ohji S, Ishiyama D, Nishio N, Otobe Y, et al. Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy. J Geriatr Oncol 2019; 10: 835–8. doi: 10.1016/j.jgo.2019.03.017 KimuraY YamadaM OhjiS IshiyamaD NishioN OtobeY Presence of sarcopenic obesity and evaluation of the associated muscle quality in Japanese older men with prostate cancer undergoing androgen deprivation therapy J Geriatr Oncol 2019 10 835 8 10.1016/j.jgo.2019.03.017 Open DOISearch in Google Scholar

28. Kocher NJ, Jafri S, Balabhadra S, Lehman E, Gardner J, Vijay K, et al. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy? Urol Oncol 2018; 36: 156.e17–156.e22. doi: 10.1016/j.urolonc.2017.12.004 KocherNJ JafriS BalabhadraS LehmanE GardnerJ VijayK Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy? Urol Oncol 2018 36 156.e17 156.e22 10.1016/j.urolonc.2017.12.004 Open DOISearch in Google Scholar

29. Cushen SJ, Power DG, Murphy KP, McDermott R, Griffin BT, Lim M, et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel. Clin Nutr ESPEN 2016; 13: e39–45. doi: 10.1016/j.clnesp.2016.04.001 CushenSJ PowerDG MurphyKP McDermottR GriffinBT LimM Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel Clin Nutr ESPEN 2016 13 e39 45 10.1016/j.clnesp.2016.04.001 Open DOISearch in Google Scholar

30. Rier HN, Jager A, Sleijfer S, van Rosmalen J, Kock MCJM, Levin MD. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast 2017; 31: c9–15. doi: 10.1016/j.breast.2016.10.014 RierHN JagerA SleijferS van RosmalenJ KockMCJM LevinMD Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy Breast 2017 31 c9 15 10.1016/j.breast.2016.10.014 Open DOISearch in Google Scholar

31. Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, et al. Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients. Invest New Drugs 2017; 35: 436–41. doi: 10.1007/s10637-017-0464-x. Erratum in: Invest New Drugs 2017; 35: 537. doi: 10.1007/s10637-017-0475-7 HeidelbergerV GoldwasserF KramkimelN JouinotA HuillardO Boudou-RouquetteP Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients Invest New Drugs 2017 35 436 41 10.1007/s10637-017-0464-x Erratum in: Invest New Drugs 2017; 35: 537. 10.1007/s10637-017-0475-7 Open DOISearch in Google Scholar

32. Jabbour J, Manana B, Zahreddine A, Saade C, Charafeddine M, Bazarbachi A, et al. Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation. Curr Res Transl Med 2019; 67: 93–9. doi: 10.1016/j.retram.2018.12.001 JabbourJ MananaB ZahreddineA SaadeC CharafeddineM BazarbachiA Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation Curr Res Transl Med 2019 67 93 9 10.1016/j.retram.2018.12.001 Open DOISearch in Google Scholar

33. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 601. doi: 10.1093/ageing/afz046. Erratum for: Age Ageing 2019; 48: 16–31. doi: 10.1093/ageing/afy169 Cruz-JentoftAJ BahatG BauerJ BoirieY BruyèreO CederholmT Writing group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis Age Ageing 2019 48 601 10.1093/ageing/afz046 Erratum for: Age Ageing 2019; 48: 16–31. 10.1093/ageing/afy169 Open DOISearch in Google Scholar

34. Mei KL, Batsis JA, Mills JB, Holubar SD. Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Perioper Med 2016; 5: 30. doi: 10.1186/s13741-016-0052-1 MeiKL BatsisJA MillsJB HolubarSD Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery? Perioper Med 2016 5 30 10.1186/s13741-016-0052-1 Open DOISearch in Google Scholar

35. Prado CM, Heymsfield SB. Lean tissue imaging: a new era for nutritional assessment and intervention. JPEN J Parenter Enteral Nutr 2014; 38: 940–53. doi: 10.1177/0148607114550189. Erratum in: JPEN J Parenter Enteral Nutr 2016; 40: 742. doi: 10.1177/0148607116647919 PradoCM HeymsfieldSB Lean tissue imaging: a new era for nutritional assessment and intervention JPEN J Parenter Enteral Nutr 2014 38 940 53 10.1177/0148607114550189 Erratum in: JPEN J Parenter Enteral Nutr 2016; 40: 742. 10.1177/0148607116647919 Open DOISearch in Google Scholar

36. Donini LM, Busetto L, Bauer JM, Bischoff S, Boirie Y, Cederholm T, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin Nutr 2020; 39: 2368–88. doi: 10.1016/j.clnu.2019.11.024 DoniniLM BusettoL BauerJM BischoffS BoirieY CederholmT Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review Clin Nutr 2020 39 2368 88 10.1016/j.clnu.2019.11.024 Open DOISearch in Google Scholar

37. Ji T, Li Y, Ma L. Sarcopenic obesity: an emerging public health problem. Aging Dis 2022; 13: 379–88. doi: 10.14336/AD.2021.1006 JiT LiY MaL Sarcopenic obesity: an emerging public health problem Aging Dis 2022 13 379 88 10.14336/AD.2021.1006 Open DOISearch in Google Scholar

38. Batsis JA, Villareal DT. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat Rev Endocrinol 2018; 14: 513–37. doi: 10.1038/s41574-018-0062-9 BatsisJA VillarealDT Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies Nat Rev Endocrinol 2018 14 513 37 10.1038/s41574-018-0062-9 Open DOISearch in Google Scholar

39. Lynch GM, Murphy CH, Castro EM, Roche HM. Inflammation and metabolism: the role of adiposity in sarcopenic obesity. Proc Nutr Soc 2020; 16: 1–13. doi: 10.1017/S0029665120007119 LynchGM MurphyCH CastroEM RocheHM Inflammation and metabolism: the role of adiposity in sarcopenic obesity Proc Nutr Soc 2020 16 1 13 10.1017/S0029665120007119 Open DOISearch in Google Scholar

40. Guo A, Li K, Xiao Q. Sarcopenic obesity: myokines as potential diagnostic biomarkers and therapeutic targets? Exp Gerontol 2020; 139: 111022. doi: 10.1016/j.exger.2020.111022 GuoA LiK XiaoQ Sarcopenic obesity: myokines as potential diagnostic biomarkers and therapeutic targets? Exp Gerontol 2020 139 111022 10.1016/j.exger.2020.111022 Open DOISearch in Google Scholar

41. Murton AJ, Marimuthu K, Mallinson JE, Selby AL, Smith K, Rennie MJ, et al. Obesity appears to be associated with altered muscle protein synthetic and breakdown responses to increased nutrient delivery in older men, but not reduced muscle mass or contractile function. Diabetes 2015; 64: 3160–71. doi: 10.2337/db15-0021 MurtonAJ MarimuthuK MallinsonJE SelbyAL SmithK RennieMJ Obesity appears to be associated with altered muscle protein synthetic and breakdown responses to increased nutrient delivery in older men, but not reduced muscle mass or contractile function Diabetes 2015 64 3160 71 10.2337/db15-0021 Open DOISearch in Google Scholar

42. Abbass T, Dolan RD, Laird BJ, McMillan DC. The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: A systematic review. Cancers 2019; 11: 1304. doi: 10.3390/cancers11091304 AbbassT DolanRD LairdBJ McMillanDC The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: A systematic review Cancers 2019 11 1304 10.3390/cancers11091304 Open DOISearch in Google Scholar

43. Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care – correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 2005; 103: 2189–98. doi: 10.1002/cncr.21013 FouladiunM KörnerU BosaeusI DanerydP HyltanderA LundholmKG Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care – correlations with food intake, metabolism, exercise capacity, and hormones Cancer 2005 103 2189 98 10.1002/cncr.21013 Open DOISearch in Google Scholar

44. Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers 2018; 4: 17105. doi: 10.1038/nrdp.2017.105 BaracosVE MartinL KorcM GuttridgeDC FearonKCH Cancer-associated cachexia Nat Rev Dis Primers 2018 4 17105 10.1038/nrdp.2017.105 Open DOISearch in Google Scholar

45. Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 2018; 29(Suppl 2): ii1–9. doi: 10.1093/annonc/mdx810 BaracosVE ArribasL Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy Ann Oncol 2018 29 Suppl 2 ii1 9 10.1093/annonc/mdx810 Open DOISearch in Google Scholar

46. Murphy RA, Mourtzakis M, Chu QS, Reiman T, Mazurak VC. Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients. J Nutr 2010;140: 1602–6. doi: 10.3945/jn.110.123521 MurphyRA MourtzakisM ChuQS ReimanT MazurakVC Skeletal muscle depletion is associated with reduced plasma (n-3) fatty acids in non-small cell lung cancer patients J Nutr 2010 140 1602 6 10.3945/jn.110.123521 Open DOISearch in Google Scholar

47. Martin L, Gioulbasanis I, Senesse P, Baracos VE. Cancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in over-weight and obese patients. JPEN J Parenter Enteral Nutr 2020; 44: 227–38. doi: 10.1002/jpen.1597 MartinL GioulbasanisI SenesseP BaracosVE Cancer-associated malnutrition and CT-defined sarcopenia and myosteatosis are endemic in over-weight and obese patients JPEN J Parenter Enteral Nutr 2020 44 227 38 10.1002/jpen.1597 Open DOISearch in Google Scholar

48. Correa-de-Araujo R, Addison O, Miljkovic I, Goodpaster BH, Bergman BC, Clark RV, et al. Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging. Front Physiol 2020; 11: 963. doi: 10.3389/fphys.2020.00963 Correa-de-AraujoR AddisonO MiljkovicI GoodpasterBH BergmanBC ClarkRV Myosteatosis in the context of skeletal muscle function deficit: an interdisciplinary workshop at the National Institute on Aging Front Physiol 2020 11 963 10.3389/fphys.2020.00963 Open DOISearch in Google Scholar

49. Gemmink A, Goodpaster BH, Schrauwen P, Hesselink MKC. Intramyocellular lipid droplets and insulin sensitivity, the human perspective. Biochim Biophys Acta Mol Cell Biol Lipids 2017; 1862(10 Pt B): 1242–9. doi: 10.1016/j.bbalip.2017.07.010 GemminkA GoodpasterBH SchrauwenP HesselinkMKC Intramyocellular lipid droplets and insulin sensitivity, the human perspective Biochim Biophys Acta Mol Cell Biol Lipids 2017 1862 10 Pt B 1242 9 10.1016/j.bbalip.2017.07.010 Open DOISearch in Google Scholar

50. Maltais A, Alméras N, Lemieux I, Tremblay A, Bergeron J, Poirier P, et al. Trunk muscle quality assessed by computed tomography: association with adiposity indices and glucose tolerance in men. Metabolism 2018; 85: 205–12. doi: 10.1016/j.metabol.2018.04.003 MaltaisA AlmérasN LemieuxI TremblayA BergeronJ PoirierP Trunk muscle quality assessed by computed tomography: association with adiposity indices and glucose tolerance in men Metabolism 2018 85 205 12 10.1016/j.metabol.2018.04.003 Open DOISearch in Google Scholar

51. Rollins KE, Tewari N, Ackner A, Awwad A, Madhusudan S, Macdonald IA, et al. The impact of sarcopenia and myosteatosis on outcomes of unresecTable pancreatic cancer or distal cholangiocarcinoma. Clin Nutr 2016; 35: 1103–9. doi: 10.1016/j.clnu.2015.08.005 RollinsKE TewariN AcknerA AwwadA MadhusudanS MacdonaldIA The impact of sarcopenia and myosteatosis on outcomes of unresecTable pancreatic cancer or distal cholangiocarcinoma Clin Nutr 2016 35 1103 9 10.1016/j.clnu.2015.08.005 Open DOISearch in Google Scholar

52. Knapp ML, al-Sheibani S, Riches PG, Hanham IW, Phillips RH. Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem 1991; 28 (Pt 5): 480–6. doi: 10.1177/000456329102800510 KnappML al-SheibaniS RichesPG HanhamIW PhillipsRH Hormonal factors associated with weight loss in patients with advanced breast cancer Ann Clin Biochem 1991 28 Pt 5 480 6 10.1177/000456329102800510 Open DOISearch in Google Scholar

53. Crown AL, Cottle K, Lightman SL, Falk S, Mohamed-Ali V, Armstrong L, et al. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol 2002; 56: 723–33. doi: 10.1046/j.1365-2265.2002.01540.x CrownAL CottleK LightmanSL FalkS Mohamed-AliV ArmstrongL What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol 2002 56 723 33 10.1046/j.1365-2265.2002.01540.x Open DOISearch in Google Scholar

54. Yoshikawa T, Noguchi Y, Doi C, Makino T, Nomura K. Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition 2001; 17: 590–3. doi: 10.1016/s0899-9007(01)00561-5 YoshikawaT NoguchiY DoiC MakinoT NomuraK Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure Nutrition 2001 17 590 3 10.1016/s0899-9007(01)00561-5 Open DOISearch in Google Scholar

55. Hoffmann C, Weigert C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harb Perspect Med 2017; 7: a029793. doi: 10.1101/cshperspect.a029793 HoffmannC WeigertC Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations Cold Spring Harb Perspect Med 2017 7 a029793 10.1101/cshperspect.a029793 Open DOISearch in Google Scholar

56. Jurdana M. Physical activity and cancer risk. Actual knowledge and possible biological mechanisms. Radiol Oncol 2021; 55: 7–17. doi: 10.2478/raon-2020-0063 JurdanaM Physical activity and cancer risk. Actual knowledge and possible biological mechanisms Radiol Oncol 2021 55 7 17 10.2478/raon-2020-0063 Open DOISearch in Google Scholar

57. Rivas DA, McDonald DJ, Rice NP, Haran PH, Dolnikowski GG, Fielding RA. Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity. Am J Physiol Regul Integr Comp Physiol 2016; 310: R561–9. doi: 10.1152/ajpregu.00198.2015 RivasDA McDonaldDJ RiceNP HaranPH DolnikowskiGG FieldingRA Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity Am J Physiol Regul Integr Comp Physiol 2016 310 R561 9 10.1152/ajpregu.00198.2015 Open DOISearch in Google Scholar

58. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288–95. doi: 10.1038/nm788 YamauchiT KamonJ MinokoshiY ItoY WakiH UchidaS Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 2002 8 1288 95 10.1038/nm788 Open DOISearch in Google Scholar

59. Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci 2020; 21: 494. doi: 10.3390/ijms21020494 HongSH ChoiKM Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences Int J Mol Sci 2020 21 494 10.3390/ijms21020494 Open DOISearch in Google Scholar

60. Hamrick MW. Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging. J Bone Metab 2017; 24: 1–8. doi: 10.11005/jbm.2017.24.1.1 HamrickMW Role of the cytokine-like hormone leptin in muscle-bone crosstalk with aging J Bone Metab 2017 24 1 8 10.11005/jbm.2017.24.1.1 Open DOISearch in Google Scholar

61. Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M, Valkovic L, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol 2014; 592: 1091–107. doi: 10.1113/jphysiol.2013.264655 KurdiovaT BalazM VicianM MaderovaD VlcekM ValkovicL Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies J Physiol 2014 592 1091 107 10.1113/jphysiol.2013.264655 Open DOISearch in Google Scholar

62. Johns N, Greig C, Fearon KC. Is tissue cross-talk important in cancer cachexia? Crit Rev Oncog 2012; 17: 263–76. doi: 10.1615/critrevoncog.v17.i3.40 JohnsN GreigC FearonKC Is tissue cross-talk important in cancer cachexia? Crit Rev Oncog 2012 17 263 76 10.1615/critrevoncog.v17.i3.40 Open DOISearch in Google Scholar

63. Argilés JM, Busquets S, Stemmler B, López-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 2014; 14: 754–62. doi: 10.1038/nrc3829 ArgilésJM BusquetsS StemmlerB López-SorianoFJ Cancer cachexia: understanding the molecular basis Nat Rev Cancer 2014 14 754 62 10.1038/nrc3829 Open DOISearch in Google Scholar

64. Prado CM, Baracos VE, McCargar LJ, Reiman T, Mourtzakis M, Tonkin K, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15: 2920–6. doi: 10.1158/1078-0432.CCR-08-2242 PradoCM BaracosVE McCargarLJ ReimanT MourtzakisM TonkinK Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment Clin Cancer Res 2009 15 2920 6 10.1158/1078-0432.CCR-08-2242 Open DOISearch in Google Scholar

65. Petrelli F, Cortellini A, Indini A, Tomasello G, Ghidini M, Nigro O, et al. Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis. JAMA Netw Open 2021; 4: e213520 doi: 10.1001/jamanetworkopen.2021.3520 PetrelliF CortelliniA IndiniA TomaselloG GhidiniM NigroO Association of obesity with survival outcomes in patients with cancer: a systematic review and meta-analysis JAMA Netw Open 2021 4 e213520 10.1001/jamanetworkopen.2021.3520 Open DOISearch in Google Scholar

66. Gallo M, Adinolfi V, Barucca V, Prinzi N, Renzelli V, Barrea L, et al. Expected and paradoxical effects of obesity on cancer treatment response. Rev Endocr Metab Disord 2021; 22: 681–702. doi: 10.1007/s11154-020-09597-y GalloM AdinolfiV BaruccaV PrinziN RenzelliV BarreaL Expected and paradoxical effects of obesity on cancer treatment response Rev Endocr Metab Disord 2021 22 681 702 10.1007/s11154-020-09597-y Open DOISearch in Google Scholar

67. Prado CM, Purcell SA, Laviano A. Nutrition interventions to treat low muscle mass in cancer. J Cachexia Sarcopenia Muscle 2020; 11: 366–80. doi: 10.1002/jcsm.12525 PradoCM PurcellSA LavianoA Nutrition interventions to treat low muscle mass in cancer J Cachexia Sarcopenia Muscle 2020 11 366 80 10.1002/jcsm.12525 Open DOISearch in Google Scholar

68. Argilés JM, Busquets S, López-Soriano FJ, Costelli P, Penna F. Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2012; 3: 73–6. doi: 10.1007/s13539-012-0067-5 ArgilésJM BusquetsS López-SorianoFJ CostelliP PennaF Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 2012 3 73 6 10.1007/s13539-012-0067-5 Open DOISearch in Google Scholar

69. Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM. Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. Crit Rev Oncol Hematol 2013; 88: 573–93. doi: 10.1016/j.critrevonc.2013.07.001 SteneGB HelbostadJL BalstadTR RiphagenII KaasaS OldervollLM Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review Crit Rev Oncol Hematol 2013 88 573 93 10.1016/j.critrevonc.2013.07.001 Open DOISearch in Google Scholar

70. Galvão DA, Newton RU. Review of exercise intervention studies in cancer patients. J Clin Oncol 2005; 23: 899–909. doi: 10.1200/JCO.2005.06.085 GalvãoDA NewtonRU Review of exercise intervention studies in cancer patients J Clin Oncol 2005 23 899 909 10.1200/JCO.2005.06.085 Open DOISearch in Google Scholar

71. Poggiogalle E, Parrinello E, Barazzoni R, Busetto L, Donini LM. Therapeutic strategies for sarcopenic obesity: a systematic review. Curr Opin Clin Nutr Metab Care 2021; 24: 33–41. doi: 10.1097/MCO.0000000000000714 PoggiogalleE ParrinelloE BarazzoniR BusettoL DoniniLM Therapeutic strategies for sarcopenic obesity: a systematic review Curr Opin Clin Nutr Metab Care 2021 24 33 41 10.1097/MCO.0000000000000714 Open DOISearch in Google Scholar

72. Verschueren SM, Bogaerts A, Delecluse C, Claessens AL, Haentjens P, Vanderschueren D, et al. The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial. J Bone Miner Res 2011; 26: 42–9. doi: 10.1002/jbmr VerschuerenSM BogaertsA DelecluseC ClaessensAL HaentjensP VanderschuerenD The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: a 6-month randomized, controlled trial J Bone Miner Res 2011 26 42 9 10.1002/jbmr Open DOISearch in Google Scholar

73. Gyergyek, A, Rotovnik Kozjek N, Klen, J. Monitoring the effect of perioperative nutritional care on body composition and functional status in patients with carcinoma of gastrointestinal and hepatobiliary system and pancreas. Radiol Oncol 2023; 57: 371–9. doi: 10.2478/raon-2023-0028 GyergyekA Rotovnik KozjekN KlenJ Monitoring the effect of perioperative nutritional care on body composition and functional status in patients with carcinoma of gastrointestinal and hepatobiliary system and pancreas Radiol Oncol 2023 57 371 9 10.2478/raon-2023-0028 Open DOISearch in Google Scholar